Beta Blockers in Heart Failure: More Evidence for an Old Friend.
作者信息
Baek Sang Hong
机构信息
Cardiovascular Medicine Division, Department of Internal Medicine, The Catholic University of Korea, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
出版信息
J Korean Med Sci. 2018 Jun 5;33(25):e196. doi: 10.3346/jkms.2018.33.e196. eCollection 2018 Jun 18.
Abstract
摘要
相似文献
1
Beta Blockers in Heart Failure: More Evidence for an Old Friend.心力衰竭中的β受体阻滞剂：老朋友的更多证据
J Korean Med Sci. 2018 Jun 5;33(25):e196. doi: 10.3346/jkms.2018.33.e196. eCollection 2018 Jun 18.
2
Beta-blocker efficacy according to heart rate and rhythm in patients with heart failure. Commentary on the Cardiac Insufficiency Bisoprolol Study II analysis.心力衰竭患者中β受体阻滞剂根据心率和心律的疗效。关于心脏不全比索洛尔研究II分析的评论
Card Electrophysiol Rev. 2003 Sep;7(3):233-5. doi: 10.1023/B:CEPR.0000012389.01561.27.
3
Effects of bisoprolol on heart rate variability in heart failure.比索洛尔对心力衰竭患者心率变异性的影响。
Am J Cardiol. 1996 Mar 15;77(8):612-7. doi: 10.1016/s0002-9149(97)89316-2.
4
[Heart failure studies are transferrable to everyday practice. No fear of beta blockers!].[心力衰竭研究可应用于日常实践。无需惧怕β受体阻滞剂！]
MMW Fortschr Med. 2002 Oct 31;144(44):56.
5
Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.比索洛尔与卡维地洛滴定至目标剂量治疗老年心力衰竭患者：CIBIS-ELD 试验。
Eur J Heart Fail. 2011 Jun;13(6):670-80. doi: 10.1093/eurjhf/hfr020. Epub 2011 Mar 23.
6
beta-blockers in heart failure--much more than heart rate reduction.心力衰竭中的β受体阻滞剂——作用远不止降低心率。
J Card Fail. 2002 Dec;8(6):379-80. doi: 10.1054/jcaf.2002.130310.
7
Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure.选择性和非选择性β受体阻滞剂对慢性心力衰竭患者静息能量产生率及全身底物利用的影响。
J Card Fail. 2002 Dec;8(6):369-78. doi: 10.1054/jcaf.2002.130238.
8
Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.β受体阻滞剂在慢性心力衰竭和慢性阻塞性肺疾病患者中的差异：一项随机交叉试验。
J Am Coll Cardiol. 2010 Apr 27;55(17):1780-7. doi: 10.1016/j.jacc.2010.01.024.
9
Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.卡维地洛、比索洛尔和美托洛尔控释/缓释制剂对心力衰竭血液透析患者的预后益处：一项为期10年的队列研究
J Am Heart Assoc. 2016 Jan 6;5(1):e002584. doi: 10.1161/JAHA.115.002584.
10
A comparison of the beta1-selectivity of three beta1-selective beta-blockers.三种β1选择性β受体阻滞剂的β1选择性比较。
J Clin Pharm Ther. 2003 Jun;28(3):179-86. doi: 10.1046/j.1365-2710.2003.00477.x.
引用本文的文献
1
CircHIPK3 Plays Vital Roles in Cardiovascular Disease.环状HIPK3在心血管疾病中发挥重要作用。
Front Cardiovasc Med. 2021 Sep 29;8:733248. doi: 10.3389/fcvm.2021.733248. eCollection 2021.
2
Circ-HIPK3 Strengthens the Effects of Adrenaline in Heart Failure by MiR-17-3p - ADCY6 Axis.环状 RNA-HIPK3 通过 miR-17-3p-ADCY6 轴增强肾上腺素在心力衰竭中的作用。
Int J Biol Sci. 2019 Sep 7;15(11):2484-2496. doi: 10.7150/ijbs.36149. eCollection 2019.
本文引用的文献
1
Impact of Heart Rate Reduction with Maximal Tolerable Dose of Bisoprolol on Left Ventricular Reverse Remodeling.最大耐受剂量比索洛尔降低心率对左心室逆重构的影响。
J Korean Med Sci. 2018 May 11;33(25):e171. doi: 10.3346/jkms.2018.33.e171. eCollection 2018 Jun 18.
2
Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction.心率、β受体阻滞剂的使用与射血分数降低的心力衰竭结局
Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):3-11. doi: 10.1093/ehjcvp/pvy011.
3
Myocardial microRNAs associated with reverse remodeling in human heart failure.与人类心力衰竭逆重构相关的心肌 microRNAs。
JCI Insight. 2017 Jan 26;2(2):e89169. doi: 10.1172/jci.insight.89169.
4
Optimal Use of Beta-Blockers for Congestive Heart Failure.β受体阻滞剂在充血性心力衰竭中的最佳应用
Circ J. 2016;80(3):565-71. doi: 10.1253/circj.CJ-16-0101. Epub 2016 Feb 19.
5
Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study.β-1肾上腺素能受体基因多态性对韩国心力衰竭患者比索洛尔治疗耐受性和疗效的影响：心力衰竭中β肾上腺素能受体基因多态性与比索洛尔治疗的关联（ABBA）研究
Korean J Intern Med. 2016 Mar;31(2):277-87. doi: 10.3904/kjim.2015.043. Epub 2016 Feb 16.
6
Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: A multicenter study.利用ST2-R2评分预测心力衰竭患者的生存率及逆向重构程度：一项多中心研究
Int J Cardiol. 2016 Feb 1;204:242-7. doi: 10.1016/j.ijcard.2015.11.163. Epub 2015 Nov 24.
Zotero 插件